PDF herunterladen
Semin Liver Dis 2020; 40(01): 091-100
DOI: 10.1055/s-0039-1698826
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Cholemic Nephropathy Reloaded

Authors

  • Peter Fickert

    1   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

  • Alexander R. Rosenkranz

    2   Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
18. Oktober 2019 (online)

  Lizenzen und Reprints
Preview

Abstract

Acute kidney injury (AKI) is a dreaded complication in patients with liver disease and jaundice, since it is associated with significant morbidity and mortality. Cholemic nephropathy (CN) is thought to represent a widely underestimated important cause of AKI in advanced liver diseases with jaundice. The umbrella term CN describes impaired renal function along with histomorphological changes consisting of intratubular cast formation and tubular epithelial cell injury directed primarily toward distal nephron segments. In cholestasis, biliary constituents may be excreted via the kidney and bilirubin or bile acids may trigger tubular injury and cast formation, but as we begin to understand the underlying pathophysiologic mechanisms, we become increasingly aware of the urgent need for clearly defined diagnostic criteria. In the following, we aim to summarize current knowledge of clinical and morphological characteristics of CN, discuss potential pathomechanisms, and raise key questions to stimulate evolution of a research strategy for CN.

Keywords

acute kidney injury - cholestasis - hepatorenal syndrome - advanced liver disease - jaundice